

Welcome to our scientific library!
Explore more of our expertise, R&D findings and analytical know-how by accessing this large portfolio of documents compiling both technical and regulatory information.
Monoclonal antibodies (mAbs) represent a large part of pharmaceuticals currently under development. Monoclonal antibodies are 150 kDa molecules consisting of two heavy chains of ~50 kDa and two light chains of ~25 kDa connected by disulphide bridges.
The production of monoclonal antibodies (mAbs) is a lengthy and complex process. It is, however, important to follow the mAb during
Although drug products issued from biotechnology have now been on the market for many years, accurate protein quantification remains a